Clinical Trial Update: A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study from Georgetown University evaluating the combination of gemcitabine and CyberKnife radiation therapy for pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: Georgetown University | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED